Publications by authors named "E Aldana"

Background: Perioperative cognitive dysfunction (PCD) is a very prevalent clinical syndrome due to the progressive aging of the surgical population.The aim of our study is to evaluate the clinical practice of Spanish anesthesiologists surveyed regarding this entity.

Material And Methods: Prospective online survey conducted by the Neurosciences Section and distributed by SEDAR.

View Article and Find Full Text PDF

CaiB is a DR cluster actinobacteriophage that was isolated from soil in Florida using Gordonia rubripertincta NRRL B-16540 as the host. The genome is 61,620 bp, has a GC content of 68.6%, and contains 85 predicted protein coding genes.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates new treatment options for acute leukemia (AL) by testing how patient-derived leukemic cells respond to chemotherapy and natural extracts like Anamu SC and P2Et.
  • It involves analyzing bone marrow samples from 26 newly diagnosed and 6 relapsed AL patients, determining their responsiveness as either good or bad based on ex vivo tests.
  • Findings suggest that the ex vivo response to treatments correlates with patient outcomes, indicating the potential for these tests to predict treatment responses and enhance therapy effectiveness.
View Article and Find Full Text PDF

The present work aims to establish a guide to action, agreed by anaesthesiologists and neurophysiologists alike, to perform effective intraoperative neurophysiological monitoring for procedures presenting a risk of functional neurological injury, and neurosurgical procedures. The first section discusses the main techniques currently used for intraoperative neurophysiological monitoring. The second exposes the anaesthetic and non-anaesthetic factors that are likely to affect the electrical records of the nervous system structures.

View Article and Find Full Text PDF

Purpose Of Review: Myotonic dystrophy type 1 is a multisystemic disorder caused by a noncoding triplet repeat. The age of onset is variable across the lifespan, but in its most severe form, the symptoms appear at birth (congenital myotonic dystrophy) or in the pediatric age range (childhood-onset myotonic dystrophy). These children have a range of disabilities that reduce the lifespan and cause significant morbidity.

View Article and Find Full Text PDF